Fnu Sreekanth

New York City Health and Hospitals Corporation

Papers

1

Total Citations

2

H-Index

1

About

Dr. Fnu Sreekanth is a pioneering surgeon whose research focuses on advancing minimally invasive hepatobiliary surgery, particularly through the comparative analysis of robotic-assisted and laparoscopic techniques. His most cited work, a 2025 retrospective analysis, directly addresses a critical gap in surgical literature by evaluating robotic-assisted subtotal cholecystectomy—a high-risk procedure reserved for difficult gallbladders where the hepatocystic triangle cannot be safely visualized. While prior studies have largely compared open versus laparoscopic approaches, Dr. Sreekanth’s investigation provides the first robust data on robotic outcomes in this challenging context, examining surgical efficacy and postoperative interventions. With 2 citations already in its publication year, this study is rapidly gaining traction among surgeons seeking evidence-based guidance for complex biliary cases. His contributions are particularly significant for advancing robotic surgery’s role in managing the most technically demanding cholecystectomies, offering potential improvements in patient safety and recovery. Dr. Sreekanth’s work positions him at the forefront of integrating robotic platforms into high-stakes hepatobiliary procedures, making him a key voice in the evolution of minimally invasive surgical standards.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Comparative Outcomes of Robotic Assisted Versus Laparoscopic Subtotal Cholecystectomy: A Retrospective Analysis of Surgical Efficacy and Postoperative Intervention
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: New York City Health and Hospitals Corporation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago